Volmar CH
University of Miami
H-index: 24
North America-United States
Top articles of Volmar CH
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Identifying class 1 HDACs as a vulnerability for aggressive uveal melanoma | Cancer Research | Gulum Yenisehirli Ashley Zuniga Sara Rodriguez Emily V Adis Gabriela Quintana | 2024/3/22 |
Diversifying the breast cancer cell line repository with ACRJ-BC24, ACRJ-BC24α, and ACRJ-BC24β: Novel TNBC cell lines derived from an Afro-Caribbean patient | Cancer Research | Isabella Allen Shannique Clarke Jovanka Ravix Alex P Sanchez Covarrubias Ayodele Omotoso | 2024/3/22 |
Combination drug screen identifies novel epigenetic therapies to enhance menin inhibitor efficacy in KMT2A rearranged and NPM1 mutant AML | Cancer Research | Tulasigeri M Totiger Sana Chaudhry Skye Montoya Maurizio Affer Anya K Sondhi | 2024/3/22 |
Amplifying gene expression with RNA-targeted therapeutics | Olga Khorkova Jack Stahl Aswathy Joji Claude-Henry Volmar Claes Wahlestedt | 2023/7 | |
A new strategy for Alzheimer’s disease: low‐dose combination of radiotherapy and pharmacological epigenetic perturbation | Alzheimer's & Dementia | Claude‐Henry Volmar Natalie R Ricciardi Farzaneh Modarresi Ines Lohse Nadja S Andrade | 2023/12 |
Transcriptomics for clinical and experimental biology research: hang on a seq | Tanner Stokes Haoning Howard Cen Philipp Kapranov Iain J Gallagher Andrew A Pitsillides | 2023/6 | |
Long non-coding RNA-targeting therapeutics: discovery and development update | Olga Khorkova Jack Stahl Aswathy Joji Claude-Henry Volmar Zane Zeier | 2023/9/2 | |
Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse | Biomolecules | Jessica Dennison Armando Mendez Angela Szeto Ines Lohse Claes Wahlestedt | 2023/8/29 |
Nucleic acid-based therapeutics for the treatment of central nervous system disorders | Robyn McCartan Olga Khorkova Claude-Henry Volmar Claes Wahlestedt | 2023/8/16 | |
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease | Roshni C Lalwani Claude-Henry Volmar Claes Wahlestedt Keith A Webster Lina A Shehadeh | 2023/12/6 | |
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models | Molecular neurobiology | Natalie R Ricciardi Farzaneh Modarresi Ines Lohse Nadja S Andrade Ian R Newman | 2023/8 |
Selective RNA‐targeting of mTORC1 and 2 to ameliorate Alzheimer’s Disease pathogenesis | Alzheimer's & Dementia | Jack Stahl Aswathy Joji Olga Khorkova Claude‐Henry Volmar Claes Wahlestedt | 2023/12 |
Development of formulated resveratrol (micellar resveratrol) as a small molecule treatment for MPS I | Molecular Genetics and Metabolism | Shaun Brothers Claude-Henry Volmar Nancy T Chee Claes Wahlestedt Marshall Hayward | 2022/2/1 |
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease | Elife | James A Timmons Andrew Anighoro Robert J Brogan Jack Stahl Claes Wahlestedt | 2022/1/17 |
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model (vol 86, pg 173, 2022) | Journal of Alzheimer's disease | Jessica L Dennison Claude-Henry Volmar Farzaneh Modarresi Danbing Ke James Wang | 2022/1/1 |
Natural antisense transcripts as drug targets | Frontiers in Molecular Biosciences | Olga Khorkova Jack Stahl Aswathy Joji Claude-Henry Volmar Zane Zeier | 2022/9/27 |
Functional drug screening of small molecule inhibitors of epigenetic modifiers in refractory AML patients | Cancers | Jessica L Dennison Hassan Al-Ali Claude-Henry Volmar Shaun Brothers Justin Watts | 2022/8/24 |
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM) | AAPS open | Christopher Kemper Dariush Behnam Shaun Brothers Claes Wahlestedt Claude-Henry Volmar | 2022/6/30 |
Methods for Treating Mucopolysaccharidosis | 2021/1/14 | ||
Sexual dimorphism in the 3xTg-AD mouse model and its impact on pre-clinical research | Jessica L Dennison Natalie R Ricciardi Ines Lohse Claude-Henry Volmar Claes Wahlestedt | 2021/1/1 |